809237-72-7

Upstream product

• 809237-65-8 N-[1-(cyclohexylmethyl)-2-(1,1-dimethylethyl)-1H-benzimidazol-5-yl]-N-methyl-acetamide 

Downstream Products

• 849434-31-7 N-[2-tert-butyl-1-(cyclohexylmethyl)-1H-benzimidazol-5-yl]-N,N',N'-trimethylsulfamide 
• 849349-02-6 5-bromo-N-[2-tert-butyl-1-(cyclohexylmethyl)-1H-benzimidazol-5-yl]-6-chloro-N-methylpyridine-3-sulfonamide 
• 849434-33-9 N-[2-tert-butyl-1-(cyclohexylmethyl)-1H-benzimidazol-5-yl]-N',N'-diethyl-N-methylsulfamide 
• 849349-51-5 4-bromo-N-[1-(cyclohexylmethyl)-2-(1,1-dimethylethyl)-1H-benzimidazol-5-yl]-N-methyl-benzenesulfonamide 
• 849348-19-2 4-amino-N-[2-tert-butyl-1-(cyclohexylmethyl)-1H-benzimidazol-5-yl]-N-methylbenzenesulfonamide 
• 1222558-90-8 C₂₆H₃₅N₅O₃S 

Relevant academic research and scientific papers

5-sulfonamide benzimidazoles: A class of cannabinoid receptors agonists with potent in vivo antinociception activity

The synthesis and biological evaluation of a novel class of cannabinoid receptor agonists based on a 5-sulfonamide benzimidazole scaffold are reported. They showed a high binding affinity to both receptors with great in vivo potency. When given orally to

Benzimidazole Derivatives, Compositions Containing Them, Preparation Thereof and Uses Thereof

Compounds of Formula (I) or pharmaceutically acceptable salts thereof; wherein R1, R2, R3, and R4 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

COMPOUNDS, COMPOSITIONS CONTAINING THEM, PREPARATION THEREOF AND USES THEREOF III

Compounds of Formula I, or pharmaceutically acceptable salts thereof: I (chemical formula to be inserted here - please see paper copy) wherein R1, R2, R3, R4, R5, R6 and G are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

BENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING THEM, PREPARATION THEREOF AND USES THEREOF

Compounds of Formula (I) or pharmaceutically acceptable salts thereof; wherein R1, R2, R3, and R4 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

BENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING THEM, PREPARATION THEROF AND USES THEREOF

Compounds of Formulae (IA), (IB) or pharmaceutically acceptable salts thereof; wherein Het, X1, R1, R2, R3, R3a and R4 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

BENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING THEM, PREPARATION THEREOF AND USES THEREOF

Compounds of Formula (I) or pharmaceutically acceptable salts thereof; wherein R1, R2, R3, R4, n and Ar are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

BENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING THEM, PREPARATION THEREOF AND USES THEREOF

Compounds of Formula (I) or pharmaceutically acceptable salts thereof; wherein R1, R2, R3 and Ar are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

BENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING THEM, PREPARATION THEREOF AND USES THEREOF

Compounds of formula (I) or pharmaceutically acceptable salts thereof: wherein R1, R2, R3, R4 and Z are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.